Estabrook Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Estabrook Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,500	Closed	-$243K	–	377
2017 Q4	$243K	Hold	4,500	–	–	0.04%	126
2017 Q3	$257K	Hold	4,500	–	–	0.04%	125
2017 Q2	$271K	Hold	4,500	–	–	0.04%	122
2017 Q1	$245K	Buy	+4,500	New	+$222K	0.04%	129

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Estabrook Capital Management's BIVV Position: Q1 2018 in Review

Estabrook Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 4,500 shares — an estimated $243K sold.

Estabrook Capital Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $271K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Estabrook Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Estabrook Capital Management sold 4,500 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $243K.
Estabrook Capital Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Estabrook Capital Management's Bioverativ Inc. Common Stock position peaked at $271K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Estabrook Capital Management's 13F filing for Q1 2018, filed 14 May 2018.